GEM
IMPV

Global Endowment Management’s Imperva, Inc. IMPV Stock Holding History

Global Endowment Management’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,400
Closed -$390K – 244
2018
Q3 		$390K Buy
+8,400
New +$406K 0.05% 177

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Global Endowment Management's IMPV Position: Q4 2018 in Review

Global Endowment Management sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 8,400 shares — an estimated $390K sold.

Global Endowment Management first reported a position in IMPV in Q3 2018 and held it in 1 quarter. The position peaked at $390K in Q3 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Global Endowment Management reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Global Endowment Management sold 8,400 Imperva, Inc. shares in Q4 2018, an estimated $390K.
  • Global Endowment Management first reported a position in Imperva, Inc. in Q3 2018 and held it in 1 quarter.
  • Global Endowment Management's Imperva, Inc. position peaked at $390K in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Global Endowment Management's 13F filing for Q4 2018, filed 12 Feb 2019.